Close Menu

NEW YORK (GenomeWeb) – Illumina has filed a new patent infringement lawsuit against Premaitha Health in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. In the suit, Illumina alleges that Premaitha infringes on a patent it holds related to noninvasive prenatal testing.

The patent in question is one that Illumina licenses from Sequenom, the European Patent (UK) 1 524 321 B2 titled, "Non-invasive Detection of Fetal Genetic Traits." Illumina is seeking damages and injunctive relief.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.